Showing results (471-480 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|June 23, 2001
High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancementM C Pandolfino, N Labarrière, M H Tessier, et al.Cancer Immunology, Immunotherapy : CII|November 20, 2002
Adjuvant immunotherapy for solid tumors: from promise to clinical applicationSimone Mocellin, Carlo R Rossi, Mario Lise, et al.Cancer Immunology, Immunotherapy : CII|November 20, 2002
Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residuesAkihiro Tsuboi, Yoshihiro Oka, Keiko Udaka, et al.Cancer Immunology, Immunotherapy : CII|August 28, 2003
Combinations of anticancer drugs and immunotherapyMalcolm S MitchellCancer Immunology, Immunotherapy : CII|April 12, 2003
Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effectsThierry Lesimple, Annick Moisan, André Carsin, et al.Cancer Immunology, Immunotherapy : CII|September 5, 2003
In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene deliveryPing-Ying Pan, Yu Li, Qingsheng Li, et al.Cancer Immunology, Immunotherapy : CII|October 18, 2002
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patientsNathalie Labarrière, Marie-Christine Pandolfino, Nadine Gervois, et al.Cancer Immunology, Immunotherapy : CII|October 18, 2002
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanomaBrigitte Dréno, Jean-Michel Nguyen, Amir Khammari, et al.Cancer Immunology, Immunotherapy : CII|January 22, 2003
Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinomaBrian D Badgwell, Daniel J Valentino, Edward B Jeffes, et al.Cancer Immunology, Immunotherapy : CII|January 22, 2003
A series of immune responses leading to the induction of T cell IL-12/IL-18 responsiveness in patients with relatively large tumor burdensKazuko Uno, Yoko Mitsuishi, Mari Tanigawa, et al.Pageof 650